QUILASTA Trademark

Trademark Overview

On Wednesday, October 16, 2019, a trademark application was filed for QUILASTA with the United States Patent and Trademark Office. The USPTO has given the QUILASTA trademark a serial number of 88656596. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 22, 2023. This trademark is owned by Medimetriks Pharmaceuticals, Inc.. The QUILASTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for dermatologic use in treating skin disorders
quilasta

General Information

Serial Number88656596
Word MarkQUILASTA
Filing DateWednesday, October 16, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 22, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparation for dermatologic use in treating skin disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedimetriks Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFairfield, NJ 07004
Party NameMedimetriks Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFairfield, NJ 07004

Trademark Events

Event DateEvent Description
Monday, May 22, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 22, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 31, 2022SOU EXTENSION 5 GRANTED
Wednesday, August 31, 2022SOU EXTENSION 5 FILED
Wednesday, August 31, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 18, 2022TEAS EXTENSION RECEIVED
Friday, March 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 23, 2022SOU EXTENSION 4 GRANTED
Wednesday, March 23, 2022SOU EXTENSION 4 FILED
Wednesday, March 23, 2022TEAS EXTENSION RECEIVED
Sunday, October 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, October 24, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sunday, October 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, October 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 12, 2021SOU EXTENSION 3 GRANTED
Tuesday, October 12, 2021SOU EXTENSION 3 FILED
Tuesday, October 12, 2021TEAS EXTENSION RECEIVED
Saturday, March 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 25, 2021SOU EXTENSION 2 GRANTED
Thursday, March 25, 2021SOU EXTENSION 2 FILED
Thursday, March 25, 2021TEAS EXTENSION RECEIVED
Tuesday, October 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 9, 2020SOU EXTENSION 1 GRANTED
Friday, October 9, 2020SOU EXTENSION 1 FILED
Friday, October 9, 2020TEAS EXTENSION RECEIVED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2020ASSIGNED TO EXAMINER
Saturday, October 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 19, 2019NEW APPLICATION ENTERED

Related Keywords

quilasta skin disorders treating dermatologic preparation pharmaceutical